Clinical Trial Update: Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 trial update on encapsulated cell implant delivering CNTF for early-stage Retinitis Pigmentosa; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• CNTF-releasing encapsulated cell implant

Snippet

Sponsor: Neurotech Pharmaceuticals | Conditions: Retinitis Pigmentosa, Usher Syndrome Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2023-02-14